Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/137159
| Title: | Real-world short and long-term effectiveness of risankizumab in refractory Crohn’s disease: RISANCROHN study from the ENEIDA Registry | Authors: | Barreiro-de Acosta, M. Nieto-Garcia, L. Poncela, M. Aguas, M. Martinez Cuevas, C. Argüelles-Arias, F. Calvo, M. Gargallo-Puyuelo, C.J. Zabalza, L. P. Varela Trastoy, Bosca-Watts, M.M. Ceballos Santos, Daniel Sebastián |
UNESCO Clasification: | 32 Ciencias médicas 320503 Gastroenterología |
Issue Date: | 2025 | Publisher: | Oxford University Press | Conference: | 20th European Crohn’s and Colitis Organization Inflammatory Bowel Diseases | URI: | https://accedacris.ulpgc.es/handle/10553/137159 | Source: | European Crohn’s and Colitis Organization / #P0609: jjae190.0783, pp. 1208-1209 (Febrero 2025) |
| Appears in Collections: | Póster de congreso |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.